000			01090nam a22002897a 4500
003			CUTN
005			20251204105207.0
008			251204b |||||||| |||| 00| 0 eng d
041			_aEnglish
082			_223 _a616.833 _bPRA
100			_aPraveen, Irene Mary.
245			_aUnderstanding the Neuroprotective Mechanism of Ginkgolide B in Mouse Model of Parkinson's Disease/ _cIrene Mary Praveen & Latchoumycandane Calivarathan.
260			_aThiruvarur: _bCUTN, _c2025.
300			_aix, 126p.: _bill., _c30 cm.
650			_aParkinson disease.
650			_aParkinson disease — Drug therapy.
650			_aParkinson disease — Pathophysiology.
650			_aNeuroprotective agents.
650			_aGinkgo biloba.
650			_aMice — Models. Neuropharmacology.
650			_aDopaminergic neurons — Degeneration — Protection.
650			_aNeuroinflammation — Experimental models.
650			_aExperimental therapeutics — Animal models.
690			_aDepartment of Biotechnology.
700			_aCalivarathan, Latchoumycandane.
942			_2ddc _cTDP
999			_c46266 _d46266